Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Legend Biotech
Pharma
Takeda, Sun, Ono—Fierce Pharma Asia
Takeda sharpens its oncology focus. Sun Pharma buys PD-L1 developer Checkpoint Therapeutics. Ono obtained an ASO from Ionis. Plus more.
Angus Liu
Mar 14, 2025 8:45am
J&J, Legend to invest $150M in Belgium cell therapy facility
Mar 12, 2025 2:15pm
A $410M obesity debut, Legend, BeiGene and more—Fierce Pharma Asia
Jan 10, 2025 9:00am
Should BeiGene or Legend sell itself in 2025?
Jan 9, 2025 9:15am
GenScript sets up operations and logistics center in Australia
Nov 11, 2024 10:59am
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
